
Opinion|Videos|January 31, 2025
Partnering With Patient Advocacy Groups to Improve HS Awareness and Outcomes
Author(s)Hadar Lev-Tov, MD
Panelist discusses how patient advocacy groups act as critical bridges between patients, researchers, and health care providers, ultimately improving recognition, treatment, and quality of life for individuals affected by hidradenitis suppurativa.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Can you discuss the role of patient advocacy groups in promoting early recognition and comprehensive care for HS?
- Closing thoughts on HS for the AJMC viewing audience.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
In Its 50th Year, ESMO Comes to Berlin, a City Transformed
2
Medicare State Rankings Reveal Stark Differences in Access, Quality, and Affordability
3
Physical Activity, Vaccination May Protect Against Long COVID
4
mRNA COVID-19 Vaccines Not Associated With Major Congenital Malformations During Pregnancy
5